Stem cell mobilization in multiple myeloma patients relapsing after previous autologous hematopoietic stem cell transplantation: A multicenter report by the Polish Myeloma Study Group-Reference-Cited by-同舟云学术

Stem cell mobilization in multiple myeloma patients relapsing after previous autologous hematopoietic stem cell transplantation: A multicenter report by the Polish Myeloma Study Group

Published:2021-02-16 Issue:3 Volume:36 Page:443-453
ISSN:0733-2459
Container-title:Journal of Clinical Apheresis
language:en
Short-container-title:J Clin Apher

Author:

Drozd‐Sokołowska Joanna¹^ORCID,Waszczuk‐Gajda Anna¹^ORCID,Topczewska Magdalena²,Mańko Joanna³⁴,Hus Iwona³⁴,Szmigielska‐Kapłon Anna⁵,Nowicki Mateusz⁶^ORCID,Grygoruk‐Wiśniowska Iwona⁷,Krawczyk‐Kuliś Małgorzata⁷⁸,Romejko‐Jarosińska Joanna⁹,Frączak Ewa¹⁰,Wróbel Tomasz¹⁰,Piątkowska‐Jakubas Beata¹¹,Mądry Krzysztof¹,Boguradzki Piotr¹,Król Małgorzata¹,Kozioł Magdalena³,Hus Marek³,Kopińska Anna⁷,Dmoszyńska Anna³,Basak Grzegorz Władysław¹,Dwilewicz‐Trojaczek Jadwiga¹

Affiliation:

1. Department of Hematology, Transplantation and Internal Diseases Medical University of Warsaw Warsaw Poland

2. Faculty of Computer Science Bialystok University of Technology Bialystok Poland

3. Department of Hematooncology and Bone Marrow Transplantation Medical University of Lublin Lublin Poland

4. Department of Hematology Institute of Hematology and Transfusion Medicine Warsaw Poland

5. Department of Hematology Medical University of Lodz Lodz Poland

6. Department of Hematology Copernicus Memorial Hospital in Lodz Comprehensive Cancer Center and Traumatology Lodz Poland

7. Department of Hematology and Bone Marrow Transplantation Medical University of Silesia Katowice Poland

8. Department of Bone Marrow Transplantation and Oncohematology Maria Sklodowska‐Curie Institute‐Cancer Center Gliwice Poland

9. Department of Lymphoid Malignancies Maria Sklodowska‐Curie Memorial Cancer Centre and Institute of Oncology Warsaw Poland

10. Department of Hematology Wroclaw Medical University Wroclaw Poland

11. Department of Hematology Jagiellonian University Cracow Poland

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jca.21885

Reference36 articles.

1. High-Dose Chemotherapy with Early Autologous Stem Cell Transplantation Compared to Standard Dose Chemotherapy or Delayed Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis

2. The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial

3. Autologous Stem Cell Transplantation: An Effective Salvage Therapy in Multiple Myeloma

4. Second Autologous Stem Cell Transplantation as Salvage Therapy for Multiple Myeloma: Impact on Progression-Free and Overall Survival

5. Autologous stem cell transplantation versus novel drugs or conventional chemotherapy for patients with relapsed multiple myeloma after previous ASCT

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem Cell Mobilization Performed with Different Doses of Cytarabine in Plasma Cell Myeloma Patients Relapsing after Previous Autologous Hematopoietic Cell Transplantation—A Multicenter Report by the Polish Myeloma Study Group;Cancers;2024-07-19

2. Etoposide combined with cytarabine and pegfilgrastim for poorly mobilizing patients with multiple myeloma and lymphoma: A prospective multicentre study;British Journal of Haematology;2024-02-23

3. Cryopreservation and storage patterns of hematopoietic progenitor stem cells for multiple myeloma;Transfusion and Apheresis Science;2023-10

4. Higher efficacy of Etoposide + Cytarabine Plus Pegfilgrastim in poorly mobilizing Multiple Myeloma and lymphoma Patients;Cytotherapy;2023-08

5. Are we choosing mobilization regimens for autologous stem cell transplantation in multiple myeloma wisely: A single center comparison of GCSF +/−plerixafor vs cyclophosphamide/ GCSF +/−plerixafor;Journal of Clinical Apheresis;2022-02-26